Market Overview:
The global theranostics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Theranostics is a combination of various radioactive drugs and techniques used to diagnose, deliver therapy, and treat life-threatening illnesses. It is cost-effective and involves pharmacogenetics, proteomics, and biomarker profiling. It can be integrated with nanomedicine to target specific organs and tissues and improve patient-specific outcomes. Nowadays, researchers worldwide are developing new diagnostic and therapeutic agents for theranostics to personalize the treatment of cancer, reduce side effects of treatment, and improve the quality care of pharmacotherapy.
The rising prevalence of cancer due to the increasing consumption of tobacco and alcohol, high body mass index (BMI), low nutrition intake, and lack of physical activity represents one of the main factors stimulating the market growth. Moreover, according to the World Health Organization (WHO), cancer is the second leading cause of death globally, out of which 70% of deaths occur in low and middle-income countries. This is encouraging health and governing agencies of several countries to increase awareness about the available medical treatments and improve the healthcare infrastructure, which is positively influencing the market growth. The escalating demand for personalized medicine is also bolstering the market growth. Apart from this, the integration of seamless, multiple imaging treatment technologies within a single nanoparticle to tackle pathologies is driving the market. Furthermore, the increasing approvals to produce theranostics and rising investments in research and development (R&D) activities are other factors anticipated to propel the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global theranostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on disease type, technology and end user.
Breakup by Disease Type:
- Neurological Disorders
- Cardiovascular Diseases
- Immunological Disorders
- Oncology Diseases
- Others
Breakup by Technology:
- Polymerase Chain Reaction
- Immunohistochemistry
- In-Situ Hybridization
- Sequencing
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc (Quest Diagnostics Incorporated), Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Myriad Genetics Inc., Pfizer Inc., Qiagen N.V. and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Disease Type, Technology, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc (Quest Diagnostics Incorporated), Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Myriad Genetics Inc., Pfizer Inc., Qiagen N.V. and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global theranostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global theranostics market?
- What are the key regional markets?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global theranostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Theranostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Type
6.1 Neurological Disorders
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cardiovascular Diseases
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunological Disorders
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Oncology Diseases
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Technology
7.1 Polymerase Chain Reaction
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunohistochemistry
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-Situ Hybridization
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Sequencing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Agilent Technologies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AmeriPath Inc (Quest Diagnostics Incorporated)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Beckman Coulter Inc. (Danaher Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Becton, Dickinson and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 General Electric Company
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Illumina Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Myriad Genetics Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Pfizer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Qiagen N.V.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Theranostics Market: Major Drivers and Challenges
Figure 2: Global: Theranostics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Theranostics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Theranostics Market: Breakup by Disease Type (in %), 2020
Figure 5: Global: Theranostics Market: Breakup by Technology (in %), 2020
Figure 6: Global: Theranostics Market: Breakup by End User (in %), 2020
Figure 7: Global: Theranostics Market: Breakup by Region (in %), 2020
Figure 8: Global: Theranostics (Neurological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Theranostics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Theranostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Theranostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Theranostics (Immunological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Theranostics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Theranostics (Oncology Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Theranostics (Oncology Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Theranostics (Other Disease Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Theranostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Theranostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Theranostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Theranostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Theranostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Theranostics (In-Situ Hybridization) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Theranostics (In-Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Theranostics (Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Theranostics (Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Theranostics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Theranostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Theranostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Theranostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Theranostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Theranostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Theranostics (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Theranostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: North America: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: North America: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: United States: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: United States: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Canada: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Canada: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Asia-Pacific: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Asia-Pacific: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: China: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: China: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Japan: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Japan: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: India: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: India: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: South Korea: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: South Korea: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Australia: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Australia: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Indonesia: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Indonesia: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Others: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Others: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Europe: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Europe: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Germany: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Germany: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: France: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: France: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: United Kingdom: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: United Kingdom: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Italy: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Italy: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Spain: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Spain: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Russia: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Russia: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Latin America: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Latin America: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Brazil: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Brazil: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Mexico: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Mexico: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Others: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Others: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Middle East and Africa: Theranostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Middle East and Africa: Theranostics Market: Breakup by Country (in %), 2020
Figure 82: Middle East and Africa: Theranostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Global: Theranostics Industry: SWOT Analysis
Figure 84: Global: Theranostics Industry: Value Chain Analysis
Figure 85: Global: Theranostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Theranostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Theranostics Market Forecast: Breakup by Disease Type (in Million US$), 2021-2026
Table 3: Global: Theranostics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Theranostics Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Theranostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Theranostics Market: Competitive Structure
Table 7: Global: Theranostics Market: Key Players